TD Asset Management Portfolio holdings
AUM
$117B
1-Year Return
25.17%
This Quarter Return
+11%
1 Year Return
+25.17%
3 Year Return
+87.06%
5 Year Return
+156.45%
10 Year Return
+305.53%
AUM
$107B
AUM Growth
+$5.79B
(+5.7%)
Cap. Flow
-$2.63B
Cap. Flow
% of AUM
-2.44%
Top 10 Holdings %
Top 10 Hldgs %
24.55%
Holding
1,462
New
74
Increased
672
Reduced
527
Closed
81
Top Buys
| 1 |
AbbVie
ABBV
|
$386M |
| 2 |
Procter & Gamble
PG
|
$310M |
| 3 |
Meta Platforms (Facebook)
META
|
$292M |
| 4 |
CRH
CRH
|
$276M |
| 5 |
Republic Services
RSG
|
$267M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$1.45B |
| 2 |
Apple
AAPL
|
$780M |
| 3 |
UnitedHealth
UNH
|
$465M |
| 4 |
Microsoft
MSFT
|
$445M |
| 5 |
NVIDIA
NVDA
|
$433M |
Sector Composition
| 1 | Technology | 20.15% |
| 2 | Financials | 19.67% |
| 3 | Healthcare | 11.58% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Hyatt Hotels
H
$13.8B
| $563K | ﹤0.01% |
3,530
-200
| -5% | -$31.9K |
|
1277
AdvanSix
ASIX
$569M
| $563K | ﹤0.01% |
19,700
-8,800
| -31% | -$252K |
|
1278
Nuvation Bio
NUVB
$1.33B
| $561K | ﹤0.01% |
+154,200
| New | +$561K |
|
1279
Helios Technologies
HLIO
$1.84B
| $559K | ﹤0.01% |
12,506
-23,264
| -65% | -$1.04M |
|
1280
Kearny Financial
KRNY
$415M
| $555K | ﹤0.01% |
86,212
| – | – |
|
|
CGC
1281
Canopy Growth
CGC
$456M
| $555K | ﹤0.01% |
64,382
+12,658
| +24% | +$109K |
|
|
AZPN
1282
DELISTED
Aspen Technology Inc
AZPN
| $551K | ﹤0.01% |
2,582
-219
| -8% | -$46.7K |
|
1283
ALX Oncology
ALXO
$65.3M
| $546K | ﹤0.01% |
49,000
-21,400
| -30% | -$239K |
|
1284
Murphy USA
MUSA
$7.47B
| $545K | ﹤0.01% |
+1,300
| New | +$545K |
|
|
NOA
1285
North American Construction
NOA
$390M
| $537K | ﹤0.01% |
24,117
+500
| +2% | +$11.1K |
|
1286
Otter Tail
OTTR
$3.52B
| $536K | ﹤0.01% |
+6,200
| New | +$536K |
|
1287
BILL Holdings
BILL
$5.24B
| $528K | ﹤0.01% |
7,682
-61,868
| -89% | -$4.25M |
|
1288
Dropbox
DBX
$8.06B
| $526K | ﹤0.01% |
21,634
| – | – |
|
1289
Westlake Corp
WLK
$11.5B
| $524K | ﹤0.01% |
3,428
-100
| -3% | -$15.3K |
|
|
PRFT
1290
DELISTED
Perficient Inc
PRFT
| $523K | ﹤0.01% |
9,300
| – | – |
|
1291
Tower Semiconductor
TSEM
$7.07B
| $514K | ﹤0.01% |
15,650
+7,531
| +93% | +$247K |
|
1292
AnaptysBio
ANAB
$613M
| $509K | ﹤0.01% |
22,600
-8,800
| -28% | -$198K |
|
1293
Liberty Global Class C
LBTYK
$4.12B
| $509K | ﹤0.01% |
28,845
+7,573
| +36% | +$134K |
|
1294
Taysha Gene Therapies
TSHA
$917M
| $504K | ﹤0.01% |
175,600
| – | – |
|
1295
Transcat
TRNS
$729M
| $501K | ﹤0.01% |
4,494
| – | – |
|
1296
Gossamer Bio
GOSS
$668M
| $498K | ﹤0.01% |
422,260
-82,540
| -16% | -$97.4K |
|
1297
UroGen Pharma
URGN
$873M
| $492K | ﹤0.01% |
+32,800
| New | +$492K |
|
1298
Orchestra BioMed
OBIO
$148M
| $488K | ﹤0.01% |
92,678
| – | – |
|
|
MREO
1299
Mereo BioPharma
MREO
$282M
| $488K | ﹤0.01% |
+148,000
| New | +$488K |
|
1300
ePlus
PLUS
$1.89B
| $487K | ﹤0.01% |
6,200
-500
| -7% | -$39.3K |
|